These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39231247)

  • 21. Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant.
    Gagnon N; Boily P; Alguire C; Corbeil G; Bancos I; Latour M; Beauregard C; Caceres K; El Haffaf Z; Saad F; Olney HJ; Bourdeau I
    Endocrine; 2020 Apr; 68(1):203-209. PubMed ID: 32088909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenocortical tumors in children.
    Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
    J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Potential of Steroid Profiling by Mass Spectrometry in the Management of Adrenocortical Carcinoma.
    Rossi C; Cicalini I; Verrocchio S; Di Dalmazi G; Federici L; Bucci I
    Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32872281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC-MS/MS in Patients with Adrenocortical Carcinoma.
    Kimpel O; Altieri B; Dischinger U; Fuss CT; Kurlbaum M; Fassnacht M
    Metabolites; 2023 Dec; 14(1):. PubMed ID: 38248823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.
    Velikanova LI; Shafigullina ZR; Lisitsin AA; Vorokhobina NV; Grigoryan K; Kukhianidze EA; Strelnikova EG; Krivokhizhina NS; Krasnov LM; Fedorov EA; Sablin IV; Moskvin AL; Bessonova EA
    Horm Cancer; 2016 Dec; 7(5-6):327-335. PubMed ID: 27370636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas.
    Ye J; Qi Y; Wang W; Sun F; Wei Q; Su T; Zhou W; Jiang Y; Yuan W; Cai J; Cui B; Ning G
    Endocrine; 2012 Jun; 41(3):479-86. PubMed ID: 22311173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumoral steroid profiling of adrenal cortisol-producing adenomas by liquid chromatography- mass spectrometry.
    Teuber JP; Nanba K; Turcu AF; Chen X; Zhao L; Else T; Auchus RJ; Rainey WE; Rege J
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105924. PubMed ID: 34089832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
    De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
    Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary steroid profiling in diagnostic evaluation of an unusual adrenal mass.
    Lenders NF; Greenfield JR
    Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31778357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted metabolic profiling of urinary steroids with a focus on analytical accuracy and sample stability.
    Vogg N; Müller T; Floren A; Dandekar T; Scherf-Clavel O; Fassnacht M; Kroiss M; Kurlbaum M
    J Mass Spectrom Adv Clin Lab; 2022 Aug; 25():44-52. PubMed ID: 35910411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors.
    Kerkhofs TM; Kerstens MN; Kema IP; Willems TP; Haak HR
    Horm Cancer; 2015 Aug; 6(4):168-75. PubMed ID: 25985881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gynecomastia in a Man With Adrenal Mass.
    Saini J; Navin P; Rivera M; Bancos I
    JCEM Case Rep; 2024 Jan; 2(1):luad143. PubMed ID: 38192879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
    Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
    Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.
    Schmitz KJ; Helwig J; Bertram S; Sheu SY; Suttorp AC; Seggewiss J; Willscher E; Walz MK; Worm K; Schmid KW
    J Clin Pathol; 2011 Jun; 64(6):529-35. PubMed ID: 21471143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Immunohistochemical Markers for the Diagnosis and Prognosis of Adrenocortical Neoplasms.
    Angelousi A; Kyriakopoulos G; Athanasouli F; Dimitriadi A; Kassi E; Aggeli C; Zografos G; Kaltsas G
    J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33804047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study.
    Catalano R; Altieri B; Angelousi A; Arosio M; Bravi F; Canu L; Croci GA; Detomas M; Esposito E; Ferrante E; Ferrero S; Fuss CT; Kaltsas G; Kimpel O; Landwehr LS; Luconi M; Morelli V; Nesi G; Nozza E; Sbiera S; Serban AL; Ronchi CL; Mantovani G; Peverelli E
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors.
    Tacon LJ; Soon PS; Gill AJ; Chou AS; Clarkson A; Botling J; Stalberg PL; Skogseid BM; Robinson BG; Sidhu SB; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4591-9. PubMed ID: 19820023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep learning approach for differentiating indeterminate adrenal masses using CT imaging.
    Singh Y; Kelm ZS; Faghani S; Erickson D; Yalon T; Bancos I; Erickson BJ
    Abdom Radiol (NY); 2023 Oct; 48(10):3189-3194. PubMed ID: 37369921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiographic Characteristics of Adrenal Masses Preceding the Diagnosis of Adrenocortical Cancer.
    Nogueira TM; Lirov R; Caoili EM; Lerario AM; Miller BS; Fragoso MC; Dunnick NR; Hammer GD; Else T
    Horm Cancer; 2015 Aug; 6(4):176-81. PubMed ID: 26021762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
    de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
    Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.